Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Intellia Therapeutics, Inc.
- GRAIL, Inc.
Updated Jul 16, 2026
CHASE WILLIAM J has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $1.00M.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | GRAL | GRAIL, Inc. | A — Grant or award | 5.5K | $63.74 | $350K |
| 2026-06-10 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 9.2K | $0.00 | |
| 2026-04-17 | GRAL | GRAIL, Inc. | A — Grant or award | 408 | $49.79 | $20K |
| 2026-01-16 | GRAL | GRAIL, Inc. | A — Grant or award | 213 | $97.44 | $21K |
| 2025-10-15 | GRAL | GRAIL, Inc. | A — Grant or award | 275 | $75.52 | $21K |
| 2025-08-20 | NTLA | Intellia Therapeutics, Inc. | P — Open-market purchase | 100.0K | $10.03 | $1.00M |
| 2025-07-15 | GRAL | GRAIL, Inc. | A — Grant or award | 533 | $38.53 | $21K |
| 2024-11-01 | GRAL | GRAIL, Inc. | A — Grant or award | 210 | $13.62 | $3K |
| 2024-10-17 | GRAL | GRAIL, Inc. | A — Grant or award | 1.1K | $14.01 | $15K |
CHASE WILLIAM J is a corporate insider — currently tracked as Director of GRAIL, Inc. (GRAL). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($1.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CHASE WILLIAM J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.